Featured Articles
-
Key Opportunities For Emerging Biotechs In The Japanese Market
1/3/2023
Gain insight into how small- and mid-size pharma sponsors can successfully navigate the challenges of Japan's clinical, regulatory, and cultural environment, especially after the country has worked to ease market barriers and streamline approval processes in recent years.
-
Clinical Trials In Asia: Keeping Up With The Pace And Breadth Of A Changing Landscape
1/3/2023
Explore some of the key issues surrounding clinical development in the Asia region, highlighting several regulatory and policy changes that are influencing the operating environment.
-
Considerations When Planning And Conducting Early Stage Trials
1/3/2023
Close cooperation between major global regulatory entities and industry sponsors can help adjust processes to maximize drug development efforts, speed up access to novel therapies, and help control development costs.
-
Decentralized Trials In Japan: How COVID-19 Has Accelerated A Previously Underutilized Practice
1/3/2023
In March 2020, the FDA announced new guidance encouraging clinical trials to be decentralized. Find out how Japan is currently facing its own challenges while trying to adopt this trend.